Skip to main content
. 2019 Dec 5;21:268. doi: 10.1186/s13075-019-2064-y

Fig. 1.

Fig. 1

Circulating calprotectin levels (ng/mL) at the moment of DMARD tapering/stopping, separated by whether patients experienced a disease flare within 12 months of tapering. p values were calculated by Mann-Whitney U tests